Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 7
2003 5
2004 7
2005 7
2006 7
2007 12
2008 16
2009 10
2010 11
2011 14
2012 17
2013 16
2014 10
2015 9
2016 4
2017 4
2018 2
2019 3
2020 2
2021 2
2022 4
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

149 results

Results by year

Filters applied: . Clear all
Page 1
Predictive power of isolated high home systolic blood pressure for cardiovascular outcomes in individuals with type 2 diabetes mellitus: KAMOGAWA-HBP study.
Hosomi Y, Ushigome E, Kitagawa N, Kitagawa N, Tanaka T, Hasegawa G, Ohnishi M, Tsunoda S, Ushigome H, Nakamura N, Asano M, Hamaguchi M, Yamazaki M, Fukui M. Hosomi Y, et al. Among authors: hasegawa g. Diab Vasc Dis Res. 2023 Nov-Dec;20(6):14791641231221264. doi: 10.1177/14791641231221264. Diab Vasc Dis Res. 2023. PMID: 38063417 Free PMC article.
Younger patients and low c-peptide immunoreactivity index but not nutritional states affect fasting blood ketone levels in Japanese with type 1 diabetes after sodium-glucose cotransporter 2 inhibitor administration.
Nakajima H, Okada H, Yoshimura Y, Tanaka T, Hasegawa G, Mitsuhashi K, Kitagawa N, Okamura T, Hashimoto Y, Senmaru T, Ushigome E, Nakanishi N, Yamazaki M, Hamaguchi M, Fukui M. Nakajima H, et al. Among authors: hasegawa g. Diabetes Obes Metab. 2023 Dec;25(12):3682-3689. doi: 10.1111/dom.15262. Epub 2023 Sep 5. Diabetes Obes Metab. 2023. PMID: 37667649
Effects of dapagliflozin on renal function in type 1 diabetes patients in the real world: A retrospective multicenter study of the KAMOGAWA-A cohort.
Hironaka J, Okada H, Hamaguchi M, Sakai K, Minamida M, Kondo Y, Hashimoto Y, Kitagawa N, Yano M, Yamazaki M, Hasegawa G, Horiguchi G, Teramukai S, Fukui M. Hironaka J, et al. Among authors: hasegawa g. Diabetes Res Clin Pract. 2023 Aug;202:110794. doi: 10.1016/j.diabres.2023.110794. Epub 2023 Jun 17. Diabetes Res Clin Pract. 2023. PMID: 37336391
Impact of sustained hypertension on new cardiovascular events in patients with type 2 diabetes: KAMOGAWA-HBP study.
Yoshimura T, Ushigome E, Hata S, Takegami M, Hasegawa G, Tanaka T, Tsunoda S, Ohnishi M, Yokota I, Ushigome H, Kitagawa N, Asano M, Hamaguchi M, Yamazaki M, Fukui M. Yoshimura T, et al. Among authors: hasegawa g. J Clin Hypertens (Greenwich). 2022 Dec;24(12):1561-1567. doi: 10.1111/jch.14596. Epub 2022 Nov 15. J Clin Hypertens (Greenwich). 2022. PMID: 36378544 Free PMC article.
Insulin dose reduction in dapagliflozin combination therapy for type 1 diabetes mellitus: the RISING-STAR study.
Hamaguchi M, Yoshimura Y, Nakajima H, Tanaka T, Hasegawa G, Ishii M, Okada H, Mitsuhashi K, Kitagawa N, Okamura T, Hashimoto Y, Majima S, Senmaru T, Ushigome E, Nakanishi N, Asano M, Yamazaki M, Fukui M; RISING-STAR study group. Hamaguchi M, et al. Among authors: hasegawa g. J Clin Biochem Nutr. 2022 Sep;71(2):158-164. doi: 10.3164/jcbn.22-7. Epub 2022 May 17. J Clin Biochem Nutr. 2022. PMID: 36213793 Free PMC article.
Home-measured pulse pressure is a predictor of cardiovascular disease in type 2 diabetes: The KAMOGAWA-HBP study.
Takegami M, Ushigome E, Hata S, Yoshimura T, Kitagawa N, Hasegawa G, Tanaka T, Ohnishi M, Tsunoda S, Yokota I, Ushigome H, Asano M, Hamaguchi M, Yamazaki M, Fukui M. Takegami M, et al. Among authors: hasegawa g. Nutr Metab Cardiovasc Dis. 2022 Oct;32(10):2330-2337. doi: 10.1016/j.numecd.2022.08.006. Epub 2022 Aug 11. Nutr Metab Cardiovasc Dis. 2022. PMID: 36100493 Free article.
Multicenter, Open-Label, 2-Arm, Pilot Trial for Safe Reduction of Basal Insulin Dose Combined with SGLT2 Inhibitor in Type 1 Diabetes Mellitus: Study Protocol for a RISING-STAR Trial.
Hamaguchi M, Hashimoto Y, Tanaka T, Hasegawa G, Ishii M, Okada H, Mitsuhashi K, Kitagawa N, Ushigome E, Yamazaki M, Fukui M. Hamaguchi M, et al. Among authors: hasegawa g. Clin Med Insights Endocrinol Diabetes. 2021 Sep 27;14:11795514211040539. doi: 10.1177/11795514211040539. eCollection 2021. Clin Med Insights Endocrinol Diabetes. 2021. PMID: 34602832 Free PMC article.
Predictive power of home blood pressure measurement for cardiovascular outcomes in patients with type 2 diabetes: KAMOGAWA-HBP study.
Ushigome E, Kitagawa N, Kitagawa N, Tanaka T, Hasegawa G, Ohnishi M, Tsunoda S, Ushigome H, Yokota I, Nakamura N, Asano M, Hamaguchi M, Yamazaki M, Fukui M. Ushigome E, et al. Among authors: hasegawa g. Hypertens Res. 2021 Mar;44(3):348-354. doi: 10.1038/s41440-020-00584-z. Epub 2020 Dec 7. Hypertens Res. 2021. PMID: 33288879
149 results